Paper954014
The nitrosoureas--thoughts for the future.
Carter SK and 1 other. Cancer Treat Rep, 1976. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. The nitrosoureas--thoughts for the future. Papers, record 954014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/954014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Nitrosourea Compounds | Major topic |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Fluorouracil | |
| Gastrointestinal Neoplasms | |
| Semustine |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8595163 | Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8595163 | PubMed |
| 7462297 | Treatment of metastatic brain tumors with the combination of 1-methyl-1-nitrosourea (MNU) and cyclophosphamide. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7462297 | PubMed |
| 7309781 | Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7309781 | PubMed |
| 6928639 | DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6928639 | PubMed |
| 6249513 | Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6249513 | PubMed |
| 3888429 | Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3888429 | PubMed |
| 3405749 | Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides. | Nucleic Acids Res | 1988 | https://conductscience.org/library/papers/3405749 | PubMed |
| 3044633 | Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3044633 | PubMed |
| 2225319 | Renal effects of S10036 in man. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2225319 | PubMed |
| 159309 | Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222. | J Cancer Res Clin Oncol | 1979 | https://conductscience.org/library/papers/159309 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/954014
GET https://conductscience.org/api/papers/v1/954014/authors